World's Best Scientists 2026 revealed!
Renato D. Lopes

Renato D. Lopes

D-Index & Metrics

Medicine

D-Index
109
Citations
59268
World Ranking
5677
National Ranking
3057

Overview

Renato D. Lopes is affiliated with Duke University in the United States. Their research primarily focuses on Medicine, with a particular emphasis on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Infectious Diseases, and Internal Medicine. Their extensive publication record encompasses a broad range of topics related to these fields.

The main topics covered in Renato D. Lopes's work include:

  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life

Their frequent co-authors include:

  • John H. Alexander
  • Christopher B. Granger
  • Shaun G. Goodman
  • Roxana Mehran
  • Philippe Gabríel Steg

Renato D. Lopes has published extensively in well-established journals, with frequent contributions to:

  • Journal of the American College of Cardiology
  • Circulation
  • American Heart Journal
  • European Heart Journal
  • JAMA Cardiology

Selected recent papers authored or co-authored by Renato D. Lopes illustrate the scope and impact of their research:

  • "Initial Invasive or Conservative Strategy for Stable Coronary Disease," 2020, published in New England Journal of Medicine
  • "Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure," 2020, published in New England Journal of Medicine
  • "Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials," 2021, published in The Lancet Diabetes & Endocrinology
  • "Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19," 2020, published in JAMA
  • "Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19," 2020, published in New England Journal of Medicine

Best Publications

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.

    Bruno M Tomazini;Israel S Maia;Alexandre B Cavalcanti;Otavio Berwanger

  • Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.

    Alexandre B. Cavalcanti;Fernando G. Zampieri;Regis G. Rosa;Luciano C.P. Azevedo

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

    R.D. Lopes;G. Heizer;R. Aronson;A.N. Vora

  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

    Deepak L. Bhatt;Michael Szarek;Bertram Pitt;Christopher P. Cannon

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

    Naveed Sattar;Matthew M Y Lee;Søren L Kristensen;Kelley R H Branch

  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

    Stefan H. Hohnloser;Ziad Hijazi;Laine Thomas;John H. Alexander

  • Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Renato D. Lopes;John H. Alexander;Sana M. Al-Khatib;Jack Ansell

  • The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

    Ziad Hijazi;Jonas Oldgren;Johan Lindbäck;John H Alexander

  • Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.

    Renato D Lopes;Pedro Gabriel Melo de Barros e Silva;Remo H M Furtado;Ariane Vieira Scarlatelli Macedo

  • Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

    Sigrun Halvorsen;Dan Atar;Dan Atar;Hongqiu Yang;Raffaele De Caterina

  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Ziad Hijazi;Johan Lindbäck;John H. Alexander;Michael Hanna

  • Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

    Elaine M. Hylek;Claes Held;John H. Alexander;Renato D. Lopes

  • Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery

    Renato D. Lopes;Gail E. Hafley;Keith B. Allen;T. Bruce Ferguson

Frequent Co-Authors

John H. Alexander
John H. Alexander Duke University
Christopher B. Granger
Christopher B. Granger Duke University
Lars Wallentin
Lars Wallentin Uppsala University
Elaine M. Hylek
Elaine M. Hylek Boston University
Michael G. Hanna
Michael G. Hanna University College London
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Sana M. Al-Khatib
Sana M. Al-Khatib Duke University
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
Robert A. Harrington
Robert A. Harrington Cornell University
Paul W. Armstrong
Paul W. Armstrong University of Alberta

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens a variety of related online degrees and certification pathways. For those interested in advancing clinical expertise, cheapest online dnp programs provide a cost-effective route to earn a Doctor of Nursing Practice degree. These programs can help nurses move into leadership or specialized clinical roles.

Pharmacy is another rewarding field. Prospective pharmacists can take advantage of the best online pharmacy school options, which combine flexibility with high academic standards. These programs are ideal for students juggling work or other commitments.

Not all healthcare careers require direct patient care. For example, online schools for health information management equip students with the skills to organize and secure medical data, a vital area in today’s digital healthcare landscape.

Entry-level specialties such as medical coding also offer accessible starting points. Understanding medical billing and coding certification cost can help plan your education and launch your healthcare career in as little as a year.

Best Scientists Citing Renato D. Lopes

Trending Scientists

Recently Published Articles